Get the Stockscreener App
2.92
0.69%
0.03
After Hours:
2.92
Achieve Life Sciences Inc stock is traded at $2.92, with a volume of 1.53M.
It is up +0.69% in the last 24 hours and up +9.81% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$2.89
Open:
$2.94
24h Volume:
1.53M
Relative Volume:
1.68
Market Cap:
$149.23M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-2.6306
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
+14.12%
1M Performance:
+9.81%
6M Performance:
-8.20%
1Y Performance:
-33.94%
1-Day Range:
$2.86
$3.10
1-Week Range:
$2.545
$3.10
52-Week Range:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
2.92 | 135.94M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
Achieve Life Sciences Inc Stock (ACHV) Latest News
Achieve Life Sciences, Inc. shares fall 2.44% intraday amid FTC's challenge to Edwards Lifesciences Corp.'s acquisition of JenaValve Technology, Inc. - AInvest
Achieve Life Sciences shares rise 4.51% intraday after ETHZilla's new brand launch and Ethereum treasury strategy. - AInvest
Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering - MSN
Evaluating Achieve Life Sciences Inc. with trendline analysisForecast Cut & Free Weekly Chart Analysis and Trade Guides - Newser
Technical analysis overview for Achieve Life Sciences Inc. stockJuly 2025 Fed Impact & Fast Exit Strategy with Risk Control - Newser
Achieve (ACHV) Q2 Net Loss Hits $12.7M - AOL.com
Achieve Life Sciences Inc. stock chart pattern explainedJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - Newser
Will Achieve Life Sciences Inc. stock go up soonEarnings Recap Summary & Proven Capital Preservation Methods - Newser
Best data tools to analyze Achieve Life Sciences Inc. stock2025 Key Lessons & Risk Controlled Stock Alerts - Newser
How moving averages guide Achieve Life Sciences Inc. tradingWeekly Loss Report & Verified Momentum Stock Ideas - Newser
Identifying reversal signals in Achieve Life Sciences Inc.Market Trend Summary & Consistent Profit Trade Alerts - Newser
What does recent volatility data suggest for Bellevue Life Sciences Acquisition Corp. Equity WarrantQuarterly Profit Report & Comprehensive Market Scan Insights - Newser
Why Achieve Life Sciences Inc. stock attracts strong analyst attentionJuly 2025 Reactions & Weekly Hot Stock Watchlists - Newser
Gamble Company breakoutsWeekly Stock Recap & Daily Oversold Bounce Ideas - Newser
Achieve Life Sciences Inc. Company’s Quarterly Earnings Growth: What the Numbers Say2025 Trade Ideas & AI Powered Market Entry Strategies - Newser
Are Bears Losing Grip on Achieve Life Sciences Inc.2025 Trading Recap & Real-Time Stock Price Movement Reports - beatles.ru
Is Achieve Life Sciences Inc. stock poised for growthQuarterly Profit Summary & Precise Buy Zone Identification - Newser
XTX Topco Ltd Acquires New Shares in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Will Achieve Life Sciences Inc. Hold Gains Into Close2025 Major Catalysts & Low Drawdown Momentum Trade Ideas - classian.co.kr
Achieve Life Sciences (NASDAQ:ACHV) Releases Earnings Results, Hits Estimates - MarketBeat
What makes Achieve Life Sciences Inc. stock attractive to long term investorsPortfolio Gains Summary & High Accuracy Trade Signal Alerts - Newser
Achieve Life Sciences, Inc. shares rise 2.42% after-hours following positive earnings report. - AInvest
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q2 2025 Earnings Call Transcript - Insider Monkey
Achieve Life Sciences’ Earnings Call Highlights Progress and Challenges - TipRanks
Achieve Life Sciences, Inc. shares rise 3.60% premarket after Deutsche Bank maintains 'buy' rating on Merck KGaA. - AInvest
Signal strength of Achieve Life Sciences Inc. stock in tech scannersFree Pattern Alert With ROI Driven Strategy - Newser
ACHV: Second Quarter Results - MSN
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - 富途牛牛
When Will Achieve Life Sciences, Inc. (NASDAQ:ACHV) Turn A Profit? - Yahoo Finance
Achieve Life Sciences: Optimistic Outlook Driven by Strategic Advances and Financial Strength - AInvest
Optimistic Buy Rating for Achieve Life Sciences Driven by Strategic Advances and Financial Strength - TipRanks
Achieve Life Sciences Inc (ACHV) Q2 2025 Earnings Call Highlights: Strategic Moves and ... By GuruFocus - Investing.com Canada
Achieve Life Sciences Inc (ACHV) Q2 2025 Earnings Call Highlights: Strategic Moves and Financial Fortification - GuruFocus
Achieve Life Sciences shares fall 1.14% after-hours following Q2 earnings miss. - AInvest
Achieve Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Achieve Life Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Achieve Life Sciences Q2 2025 results match forecasts - Investing.com Australia
Achieve Life Sciences reports Q2 EPS (37c), consensus (35c) - TipRanks
Achieve Life Sciences reports Q2 EPS of 37c, beats consensus of 35c. - AInvest
Achieve Life Sciences Q2 loss per share misses estimates - MarketScreener
Achieve Life Sciences Reports Second Quarter 2025 Financial Resu - GuruFocus
ACHIEVE LIFE SCIENCES, INC. SEC 10-Q Report - TradingView
Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - GlobeNewswire
Achieve Life Sciences Q2 Earnings Preview: Expected EPS -$0.35, Revenue $0M - AInvest
Achieve Life Sciences Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
Achieve Life Sciences shares rise 3.14% premarket after OraSure Technologies appoints new Chief Commercial Officer. - AInvest
What makes Achieve Life Sciences Inc. stock price move sharplyBreakthrough financial growth - Jammu Links News
Published on: 2025-08-04 07:45:21 - Jammu Links News
What are analysts’ price targets for Achieve Life Sciences Inc. in the next 12 monthsCapitalize on market trends early - Jammu Links News
Is Achieve Life Sciences Inc. stock overvalued or undervaluedHigh-velocity capital appreciation - Jammu Links News
What catalysts could drive Achieve Life Sciences Inc. stock higher in 2025Invest smarter and grow your wealth faster - Jammu Links News
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Achieve Life Sciences Inc Stock (ACHV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Stewart Richard Alistair | Chieve Executive Officer |
Mar 17 '25 |
Buy |
2.86 |
10,000 |
28,598 |
60,876 |
0.90%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):